The FDA approved a wearable tumor-treating fields (TTFields) device (Optune Lua) for concurrent use with a PD-1/PD-L1 ...

There was a 20% drop in the estimated number of middle and high school students who recently used at least one tobacco ...

The antiviral drug tecovirimat (Tpoxx) failed to shorten the duration of mpox lesions or lower mortality among children and ...

Sacituzumab govitecan's (Trodelvy) accelerated approval in urothelial cancer will be voluntarily withdrawn, Gilead Sciences ...

Kanaparthy is a practicing internal medicine physician specializing in clinical informatics.

A type of flesh-eating worm eradicated from the U.S. in the 1960s has been spotted again in Central America, prompting ...

Surgeons at a Kentucky hospital were preparing to remove the organs from a donor who had been declared dead only to realize ...

Rachael Robertson: Hey everybody, welcome to MedPod Today, the podcast series where MedPage Today reporters share deeper ...

SAVANNAH, Ga. -- Delandistrogene moxeparvovec (Elevidys), a gene therapy approved to treat Duchenne muscular dystrophy, ...

"Our findings suggest that accelerated curriculums offer an efficient, cost-effective way to prepare medical students for the ...

Affecting all lots, serial numbers, and these models of the MiniMed 630G, 670G, 770G, and 780G products, the portable pumps ...

During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a ...